1. Home
  2. CLM vs LMAT Comparison

CLM vs LMAT Comparison

Compare CLM & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cornerstone Strategic Value Fund Inc. New

CLM

Cornerstone Strategic Value Fund Inc. New

HOLD

Current Price

$7.47

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$104.93

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLM
LMAT
Founded
N/A
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
1995
2006

Fundamental Metrics

Financial Performance
Metric
CLM
LMAT
Price
$7.47
$104.93
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$105.80
AVG Volume (30 Days)
1.5M
359.0K
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
0.93%
EPS Growth
N/A
30.57
EPS
N/A
0.68
Revenue
N/A
$249,602,000.00
Revenue This Year
N/A
$14.21
Revenue Next Year
N/A
$8.88
P/E Ratio
N/A
$155.44
Revenue Growth
N/A
13.53
52 Week Low
$6.92
$79.01
52 Week High
$8.53
$118.01

Technical Indicators

Market Signals
Indicator
CLM
LMAT
Relative Strength Index (RSI) 48.28 68.18
Support Level $7.33 $104.00
Resistance Level $7.79 $114.38
Average True Range (ATR) 0.09 3.23
MACD 0.01 1.80
Stochastic Oscillator 47.54 94.47

Price Performance

Historical Comparison
CLM
LMAT

About CLM Cornerstone Strategic Value Fund Inc. New

Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, Consumer Staples, utilities, energy, Real Estate, materials, and other sectors.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: